Congress criticises drugs industry for misleading advertising

BMJ 2002; 325 doi: (Published 14 December 2002) Cite this as: BMJ 2002;325:1379
  1. Scott Gottlieb
  1. New York

Some companies have disseminated misleading advertisements for prescription drugs, even after being cited for violations, a report issued by the US Congress says.

Congressional investigators, from the independent General Accounting Office, also said that drug advertising seemed to produce a major increase in the use of prescription drugs. The study estimated that at least 8.5 million Americans each year request and receive …

View Full Text

Log in

Log in through your institution


* For online subscription